Late effects on renal glomerular and tubular function in childhood cancer survivors

被引:34
作者
Bárdi, E [1 ]
Oláh, AV
Bartyik, K
Endreffy, E
Jenei, C
Kappelmayer, J
Kiss, C
机构
[1] Univ Debrecen, Dept Pediat, Med & Hlth Sci Ctr, H-4012 Debrecen, Hungary
[2] Univ Debrecen, Dept Clin Biochem & Mol Pathol, Med & Hlth Sci Ctr, H-4012 Debrecen, Hungary
[3] Univ Szeged, Fac Med, Dept Pediat, Albert Szent Gyorgyi Med & Pharmaceut Ctr, H-6720 Szeged, Hungary
[4] H Med Diagnost & Res Lab, Budapest, Hungary
关键词
ACE gene polymorphism; ACE-inhibitor treatment; cystatin C; late nephrotoxicity; N-acetyl-beta-D-glucosaminidase; proteinuria;
D O I
10.1002/pbc.20143
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Late nephrotoxicity among childhood cancer survivors is poorly documented. Methods. We investigated 115 patients and 86 controls assessing serum cystatin C concentration (CysC), urinary N-acetyl-beta-D-glucosaminidase activity (NAG), and microalbuminuria. Protenuria was quantified and electrophoresis performed. Polymorphism of the angiotensin convertase enzyme (ACE) gene was determined by genomic PCR. Results. CysC was elevated in Wilms tumor (WT) patients. Gross proteinuria was observed in 30 patients including three patients with progressive proteinuria who improved on ACE-inhibitor treatment. Neither patients with proteinuria nor the entire study population differed from controls with respect to ACE polymorphism. Pathologically elevated urinary NAG was noted in 38% of leukemia/ lymphoma, 54% of solid tumor, 20% of WT survivors. A similar distribution of pathoiogical microalbuminuria was found. Conclusions. Mild-to-moderate subclinical glomerular and tubular damage can be identified in many childhood cancer survivors. However, most patients experience some spontaneous recovery from acute nephrotoxicity. (C) 2004 Wiley-Liss, Inc.
引用
收藏
页码:668 / 673
页数:6
相关论文
共 32 条
  • [1] Ariceta G, 1997, MED PEDIATR ONCOL, V28, P35, DOI 10.1002/(SICI)1096-911X(199701)28:1<35::AID-MPO7>3.0.CO
  • [2] 2-U
  • [3] Arndt C, 1999, MED PEDIATR ONCOL, V32, P93, DOI 10.1002/(SICI)1096-911X(199902)32:2<93::AID-MPO4>3.0.CO
  • [4] 2-Y
  • [5] Ashraf MS, 1997, MED PEDIATR ONCOL, V28, P62, DOI 10.1002/(SICI)1096-911X(199701)28:1<62::AID-MPO12>3.0.CO
  • [6] 2-C
  • [7] LONG-TERM RENAL EFFECT OF CISPLATIN IN MAN
    BRILLET, G
    DERAY, G
    JACQUIAUD, C
    MIGNOT, L
    BUNKER, D
    MEILLET, D
    RAYMOND, F
    JACOBS, C
    [J]. AMERICAN JOURNAL OF NEPHROLOGY, 1994, 14 (02) : 81 - 84
  • [8] PARTIAL REVERSIBILITY OF CISPLATIN NEPHROTOXICITY IN CHILDREN
    BROCK, PR
    KOLIOUSKAS, DE
    BARRATT, TM
    YEOMANS, E
    PRITCHARD, J
    [J]. JOURNAL OF PEDIATRICS, 1991, 118 (04) : 531 - 534
  • [9] The insertion allele at the angiotensin I-converting enzyme gene locus is associated with insulin resistance
    Chiu, KC
    McCarthy, JE
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1997, 46 (04): : 395 - 399
  • [10] CRAFT AW, 1989, CANCER SURV, V8, P605